Real-time enrollment status for this t-cell lymphoma clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06692452 |
| Recruiting Status | Suspended |
| Condition | T-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Eric Jacobsen, MD |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of March 2, 2026: Clinical trial NCT06692452 is currently suspended participants. This clinical trial study for t-cell lymphoma is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Eric Jacobsen, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06692452 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06692452 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.